We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+4.9%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$265M
AUM Growth
+$37.5M
Cap. Flow
+$34M
Cap. Flow %
12.86%
Top 10 Hldgs %
9.25%
Holding
421
New
24
Increased
206
Reduced
145
Closed
45

Top Buys

Rank Stock Value
1
DTM icon
DT Midstream
DTM
+$1.85M
2
DK icon
Delek US
DK
+$898K
3
SMG icon
ScottsMiracle-Gro
SMG
+$843K
4
VLO icon
Valero Energy
VLO
+$783K
5
FMC icon
FMC
FMC
+$709K

Top Sells

Rank Stock Value
1
COR
Coresite Realty Corporation
COR
+$1.67M
2
XLRN
Acceleron Pharma
XLRN
+$601K
3
VTA
INVESCO DYNAMIC CREDIT OPPORTUNITIES FUND
VTA
+$551K
4
KDMN
Kadmon Holdings, Inc.
KDMN
+$448K
5
TVTX icon
Travere Therapeutics
TVTX
+$434K

Sector Composition

Rank Sector Weight
1 Real Estate 22.39%
2 Healthcare 18.38%
3 Energy 15.88%
4 Materials 14.07%
5 Utilities 13.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GLAD icon
126
Gladstone Capital
GLAD
$430M
$440K 0.17%
18,968
-3,212
-14% -$74.3K
JFR icon
127
Nuveen Floating Rate Income Fund
JFR
$1.24B
$440K 0.17%
43,260
-7,170
-14% -$73.2K
TVTX icon
128
Travere Therapeutics
TVTX
$5.27B
$438K 0.17%
14,116
-15,427
-52% -$434K
GBT
129
DELISTED
Global Blood Therapeutics, Inc.
GBT
$437K 0.17%
14,938
+3,580
+32% +$111K
DCF
130
DELISTED
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.
DCF
$433K 0.16%
46,633
-3,087
-6% -$29.2K
HALO icon
131
Halozyme
HALO
$9.66B
$432K 0.16%
10,738
+187
+2% +$6.98K
TSLX icon
132
Sixth Street Specialty
TSLX
$1.63B
$431K 0.16%
18,424
-14,399
-44% -$338K
BLW icon
133
BlackRock Limited Duration Income Trust
BLW
$492M
$430K 0.16%
25,516
-1,604
-6% -$27.3K
FRA icon
134
BlackRock Floating Rate Income Strategies Fund
FRA
$383M
$424K 0.16%
31,606
-3,503
-10% -$47.3K
SAR icon
135
Saratoga Investment
SAR
$316M
$416K 0.16%
14,147
-2,436
-15% -$70.8K
UTHR icon
136
United Therapeutics
UTHR
$26.3B
$414K 0.16%
1,918
-630
-25% -$124K
APLS
137
DELISTED
Apellis Pharmaceuticals
APLS
$413K 0.16%
8,725
+1,673
+24% +$65.9K
FOLD
138
DELISTED
Amicus Therapeutics
FOLD
$413K 0.16%
35,800
-6,869
-16% -$76.6K
HRMY icon
139
Harmony Biosciences
HRMY
$2.08B
$413K 0.16%
9,686
-4,605
-32% -$184K
SAGE
140
DELISTED
Sage Therapeutics
SAGE
$408K 0.15%
9,594
+3,314
+53% +$139K
CCXI
141
DELISTED
ChemoCentryx, Inc.
CCXI
$408K 0.15%
11,214
-4,928
-31% -$173K
BGT icon
142
BlackRock Floating Rate Income Trust
BGT
$324M
$406K 0.15%
29,022
-6,455
-18% -$88.7K
BLUE
143
DELISTED
bluebird bio
BLUE
$406K 0.15%
2,030
+977
+93% +$231K
BPMC
144
DELISTED
Blueprint Medicines
BPMC
$403K 0.15%
3,762
-1,540
-29% -$161K
PHD
145
DELISTED
Pioneer Floating Rate Fund
PHD
$403K 0.15%
34,718
-6,725
-16% -$79.5K
TBPH icon
146
Theravance Biopharma
TBPH
$874M
$402K 0.15%
36,359
+11,957
+49% +$104K
LGND icon
147
Ligand Pharmaceuticals
LGND
$5.96B
$401K 0.15%
4,165
-1,789
-30% -$165K
ENTA icon
148
Enanta Pharmaceuticals
ENTA
$370M
$400K 0.15%
5,353
-4,246
-44% -$333K
EXEL icon
149
Exelixis
EXEL
$14B
$400K 0.15%
21,880
+1,783
+9% +$34.1K
PTCT icon
150
PTC Therapeutics
PTCT
$6.29B
$400K 0.15%
10,034
-382
-4% -$14.6K
4 5
6
7 8

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
ALS
Andrew L. Share $214M AUM 14.75% 1-Year Est. Return

Virtus ETF Advisers's Q4 2021 Portfolio in Review

As of Q4 2021, Virtus ETF Advisers held 421 positions worth $265M, up 17% from $227M the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.

Virtus ETF Advisers deployed $34M of net new capital in Q4 2021, opening 24 new positions and adding to 206 existing holdings. Its largest new stake was Invivyd: 22,625 shares worth $164K.

By sector, the portfolio is most concentrated in Real Estate at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Energy.

On the sell side, the largest reduction was Travere Therapeutics, an estimated $434K trimmed.

  • Virtus ETF Advisers's largest Q4 2021 buy was Invivyd: 22,625 shares worth $164K.
  • Virtus ETF Advisers added most to DT Midstream in Q4 2021, an estimated $1.85M increase.
  • Virtus ETF Advisers's biggest Q4 2021 reduction was Travere Therapeutics, cutting an estimated $434K.
  • Virtus ETF Advisers fully exited Coresite Realty Corporation in Q4 2021, selling an estimated $1.67M.
  • Virtus ETF Advisers's ten largest holdings make up 9.2% of its $265M portfolio in Q4 2021.
  • Virtus ETF Advisers opened 24 new positions and closed 45 in Q4 2021.
  • Virtus ETF Advisers's portfolio value rose 17% quarter-over-quarter to $265M.

Based on Virtus ETF Advisers's 13F filing for Q4 2021, filed 14 Feb 2022.